UA62176U - Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type - Google Patents

Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type

Info

Publication number
UA62176U
UA62176U UAU201103168U UAU201103168U UA62176U UA 62176 U UA62176 U UA 62176U UA U201103168 U UAU201103168 U UA U201103168U UA U201103168 U UAU201103168 U UA U201103168U UA 62176 U UA62176 U UA 62176U
Authority
UA
Ukraine
Prior art keywords
left ventricle
stenocardia
impairment
heart disease
treatment
Prior art date
Application number
UAU201103168U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Михаил Васильевич Бычко
Татьяна Иосифовна Мальчевская
Татьяна Дмитриевна Залевская
Ярослав Михайлович Бычка
Юрий Васильевич Ковбасюк
Алла Васильевна Вознюк
Ярослав Иванович Клебан
Владимир Владимирович Вайда
Original Assignee
Национальный Медицинский Университет Им. А.А. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Медицинский Университет Им. А.А. Богомольца filed Critical Национальный Медицинский Университет Им. А.А. Богомольца
Priority to UAU201103168U priority Critical patent/UA62176U/en
Publication of UA62176U publication Critical patent/UA62176U/en

Links

Abstract

A method for assessing the efficacy of treating the patients with the ischemic heart disease and stenocardia and arterial hypertension with the impairment of the diastolic function of the left ventricle according to hypertrophic type provides for the comparison of the state of patient prior to and after the treatment. Prior to the treatment with Anipamil, Doppleroechocardiography is performed at rest and transmitral blood flow is measured based on the rate of the early diastolic filling. The analogous procedures are performed after the treatment with Anipamil. If the rate of the early diastolic filling in the left ventricle increases by at least 12 % as compared with that prior to the treatment, the hemodynamic result and antianginal effect are considered as the positive ones.
UAU201103168U 2011-03-18 2011-03-18 Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type UA62176U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201103168U UA62176U (en) 2011-03-18 2011-03-18 Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201103168U UA62176U (en) 2011-03-18 2011-03-18 Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type

Publications (1)

Publication Number Publication Date
UA62176U true UA62176U (en) 2011-08-10

Family

ID=50836604

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201103168U UA62176U (en) 2011-03-18 2011-03-18 Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type

Country Status (1)

Country Link
UA (1) UA62176U (en)

Similar Documents

Publication Publication Date Title
UA62176U (en) Method for assessing efficacy of treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA62810U (en) Method for assessing efficacy of treating patients with ischemic heart disease and angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71695U (en) Method for assessing efficacy of ivabradin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71708U (en) Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71709U (en) Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71706U (en) Method for assessing efficacy of isosorbid mononitrate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA80784U (en) Method for assessing efficacy of barnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA81783U (en) Method for assessing efficacy of azelnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA86076U (en) Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71694U (en) Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA70705U (en) Method for assessing efficacy of isosorbid dinitrate in treating patients with ischemic heart disease and stenocardia and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA81645U (en) Method for assessing efficacy of efonidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71703U (en) Method for assessing efficacy of atorvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA86077U (en) Method for assessing efficacy of inosine in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA68461U (en) Method for assessing efficacy of s-amlodipine in treating ischemic heart disease with angina and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
UA79251U (en) Method for assessing efficacy of aranidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA59416U (en) Method for assessment of treatment efficacy in patients with ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
UA91262U (en) Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA55225U (en) method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type
UA64627U (en) Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA61995U (en) method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
UA100785U (en) Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type
UA78726U (en) Method for assessing efficacy of telmisartan in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA64628U (en) Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA54819U (en) Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type